VAERS Bibliography for May 2004 - Vaccine Adverse Event ...

VAERS Bibliography for May 2004
1. Unlicensed Flu Vaccine Reported in USA. S.Afr.Med.J. 94 (3): 158-159; March, 2004.
2. Measles Outbreak in a Boarding School--Pennsylvania, 2003. MMWR
Morb.Mortal.Wkly.Rep. 53 (14): 306-309; April 16, 2004.
3. Progress Toward Measles Elimination--Region of the Americas, 2002-2003. MMWR
Morb.Mortal.Wkly.Rep. 53 (14): 304-306; April 16, 2004.
4. Aaby, P.; Jensen, H.; Rodrigues, A.; Garly, M. L.; Benn, C. S.; Lisse, I. M.; Simondon, F.
Divergent Female-Male Mortality Ratios Associated With Different Routine Vaccinations
Among Female-Male Twin Pairs. Int.J.Epidemiol. 33 (2): 367-373; April, 2004.
5. Ahmad, K. Vaccination Halts Meningitis Outbreak in Burkina Faso. Lancet. 363 (9417):
1290; April 17, 2004.
6. Aldrete, J. A. Smallpox Vaccination in the Early 19th Century Using Live Carriers: the
Travels of Francisco Xavier De Balmis. South.Med.J. 97 (4): 375-378; April, 2004.
7. Aylward, R. B.; Cochi, S. L. Framework for Evaluating the Risks of Paralytic Poliomyelitis
After Global Interruption of Wild Poliovirus Transmission. Bull.World Health Organ. 82 (1):
40-46; January, 2004.
8. Balkhy, H. H.; Memish, Z. A.; Bafaqeer, S.; Almuneef, M. A. Influenza a Common Viral
Infection Among Hajj Pilgrims: Time for Routine Surveillance and Vaccination.
J.Travel.Med. 11 (2): 82-86; March, 2004.
9. Barouni, A. S.; Augusto, C.; Queiroz, M. V.; Lopes, M. T.; Zanini, M. S.; Salas, C. E. BCG
Lymphadenopathy Detected in a BCG-Vaccinated Infant. Braz.J.Med.Biol.Res. 37 (5): 697-
700; May, 2004.
10. Blanco, Quiros A.; Gimenez, Sanchez F.; Asensi, Botet F.; Bernaola, Iturbe E.; De Juan,
Martin F.; Garcia, Perez J.; Garces, Sanchez M.; Gomez Campdera, J. A.; Picazo, J. J.; Pineda,
Solas, V [Vaccination Schedule of the Spanish Association of Pediatrics.
Recommendations 2004]. An.Pediatr.(Barc.). 60 (5): 468-472; May, 2004.
11. Blasiole, D. A.; Metzgar, D.; Daum, L. T.; Ryan, M. A.; Wu, J.; Wills, C.; Le, C. T.; Freed, N.
E.; Hansen, C. J.; Gray, G. C.; Russell, K. L. Molecular Analysis of Adenovirus Isolates From
Vaccinated and Unvaccinated Young Adults. J.Clin.Microbiol. 42 (4): 1686-1693; April, 2004.
12. Bredin, C. P. Tuberculosis in the Ireland of 2003: It Hasn't Gone Away. Ir.Med.J. 97 (1):
6-7; January, 2004.
13. Breeze, E.; Mangtani, P.; Price, G. M.; Kovats, S.; Roberts, J.; Fletcher, A. E. Trends in
Influenza Vaccination Uptake Among People Aged Over 74 Years, 1997-2000: Survey of 73
General Practices in Britain. BMC.Fam.Pract. 5 (1): 8; April, 2004.
14. Brydak, L. B.; Machala, M.; LAguna, P.; Rokicka-Milewska, R. Antibody Response to
Influenza Vaccination in Splenectomized Patients in Poland. J.Clin.Immunol. 24 (3): 225-
236; May, 2004.
15. Check, E. Side Effects Leave Smallpox Vaccine in Limbo. Nature. 428 (6985): 789; April
22, 2004.

16. Chi, R. C.; Neuzil, K. M. The Association of Sociodemographic Factors and Patient
Attitudes on Influenza Vaccination Rates in Older Persons. Am.J.Med.Sci. 327 (3): 113-
117; March, 2004.
17. Chodaczek, G. [Adjuvants As Factors Improving Efficiency of Vaccination]. Postepy
Hig.Med.Dosw. 58:47-59; March 2, 2004.
18. Chong, C. Y.; Lim, S. H.; Ng, W. Y.; Tee, N.; Lin, R. V. Varicella Screening and
Vaccination for Healthcare Workers at KK Women's and Children's Hospital.
Ann.Acad.Med.Singapore. 33 (2): 243-247; March, 2004.
19. Dine, M. S.; Hutchins, S. S.; Thomas, A.; Williams, I.; Bellini, W. J.; Redd, S. C. Persistence
of Vaccine-Induced Antibody to Measles 26-33 Years After Vaccination. J.Infect.Dis. 189
Suppl 1:123-30; May 1, 2004.
20. Dixon-Woods, M.; Brown, H.; Arthur, A.; Matthews, R.; Jagger, C. Organising Services for
Influenza Vaccination for Older People. J.Health Serv.Res.Policy. 9 (2): 85-90; April, 2004.
21. Everett, W. W.; Zaoutis, T. L.; Halpern, S. D.; Strom, B. L.; Coffin, S. E. Preevent
Vaccination Against Smallpox: a Survey of Pediatric Emergency Health Care Providers.
Pediatr.Infect.Dis.J. 23 (4): 332-337; April, 2004.
22. Fine, M. The Rhode Island Influenza Vaccine Experience 1995-2003: Influenza Vaccine
Price, Reimbursement, Availability, and Rhode Island's Influenza Vaccination Rate.
Med.Health R.I. 87 (3): 79-80; March, 2004.
23. Fine, M. The Rhode Island Adult Vaccination Experience 1995-2003: Public Health,
Marketplace Values, and Lessons Learned About the Integrity of Medicine As a Profession.
Med.Health R.I. 87 (3): 75-76; March, 2004.
24. Fontanesi, J.; Shefer, A. M.; Fishbein, D. B.; Bennett, N. M.; De Guire, M.; Kopald, D.;
Holcomb, K.; Stryker, D. W.; Coleman, M. S. Operational Conditions Affecting the
Vaccination of Older Adults. Am.J.Prev.Med. 26 (4): 265-270; May, 2004.
25. Ford, E. S.; Williams, S. G.; Mannino, D. M.; Redd, S. C. Influenza Vaccination Coverage
Among Adults With Asthma: Findings From the 2000 Behavioral Risk Factor Surveillance
System. Am.J.Med. 116 (8): 555-558; April 15, 2004.
26. Frederiksen, M. S.; Brenoe, E.; Trier, J. Erythema Multiforme Minor Following
Vaccination With Paediatric Vaccines. Scand.J.Infect.Dis. 36 (2): 154-155; 2004.
27. Freed, G. L. Criteria for Choosing a Specific Vaccine. Arch.Pediatr.Adolesc.Med. 158
(4): 311; April, 2004.
28. Fringuelli, E.; Lepri, E.; Camilloni, B.; Neri, M.; Carrio, E.; Russano, A.; Spinozzi, F.; Iorio, A.
M. Flow Cytometric Measurement of Intracellular IFN-Gamma Induction in Aged Subjects
Before and After Parenteral Influenza Vaccination. Dev.Biol.(Basel). 115:55-9; 2003.
29. Fuessl, H. S. [How Do We Deal With Tick Bites--Vaccination--Antibiotica--
Immunotherapy?]. MMW.Fortschr.Med. 145 (15): 35; April 10, 2003.
30. Gillet, A. M. [Is It Necessary to Vaccinate Against Variola?]. Med.Trop.(Mars.). 63 (6):
643-648; 2003.
2/5

31. Gowda, R.; Cartwright, K.; Bremner, J. A.; Green, S. T. Yellow Fever Vaccine: a
Successful Vaccination of an Immunocompromised Patient. Eur.J.Haematol. 72 (4): 299-
301; April, 2004.
32. Grondin, M. A.; Gerbaud, L.; Taillandier, S.; Jalenques, I.; Glanddier, P. Y. [Measurement of
the Prevention Policy in the Hospital]. Presse Med. 33 (6): 373-377; March 27, 2004.
33. Gupta, V.; Bandyopadhyay, S.; Bapuraj, J. R.; Gupta, A. Bilateral Optic Neuritis
Complicating Rabies Vaccination. Retina. 24 (1): 179-181; February, 2004.
34. Gurfinkel, E. P.; de la Fuente, R. L. Two-Year Follow-Up of the FLU Vaccination Acute
Coronary Syndromes (FLUVACS) Registry. Tex.Heart Inst.J. 31 (1): 28-32; 2004.
35. Hanania, N. A.; Sockrider, M.; Castro, M.; Holbrook, J. T.; Tonascia, J.; Wise, R.; Atmar, R. L.
Immune Response to Influenza Vaccination in Children and Adults With Asthma: Effect of
Corticosteroid Therapy. J.Allergy Clin.Immunol. 113 (4): 717-724; April, 2004.
36. Hanna, J. N.; Morgan, A. K.; McCulloch, B. G. Uptake of Influenza Vaccine Among
Aboriginal and Torres Strait Island Adults in North Queensland, 2003. Commun.Dis.Intell.
28 (1): 80-82; 2004.
37. Hempstead, K.; Bresnitz, E.; Howell-White, S.; Crabtree, D.; Scotto, Rosato N. Use of a
State Regulation for Adult Vaccination. Am.J.Prev.Med. 26 (4): 311-314; May, 2004.
38. Heymann, D. L. Polio Eradication: Finishing the Job and Protecting the Investment.
Bull.World Health Organ. 82 (1): 1; January, 2004.
39. Hussain, R.; Shahid, F.; Zafar, S.; Dojki, M.; Dockrell, H. M. Immune Profiling of Leprosy
and Tuberculosis Patients to 15-Mer Peptides of Mycobacterium Leprae and M.
Tuberculosis GroES in a BCG Vaccinated Area: Implications for Development of Vaccine
and Diagnostic Reagents. Immunology. 111 (4): 462-471; April, 2004.
40. Hutchins, S. S.; Baughman, A. L.; Orr, M.; Haley, C.; Hadler, S. Vaccination Levels
Associated With Lack of Measles Transmission Among Preschool-Aged Populations in the
United States, 1989-1991. J.Infect.Dis. 189 Suppl 1:108-15; May 1, 2004.
41. Hviid, A.; Stellfeld, M.; Wohlfahrt, J.; Melbye, M. Childhood Vaccination and Type 1
Diabetes. N.Engl.J.Med. 350 (14): 1398-1404; April 1, 2004.
42. Inoue, T.; Hayashi, N.; Tsuda, K. [Improvement of Tuberculin Test Results With BCG
Vaccination in Set-City Primary School Children From 2000 to 2002]. Nippon Koshu Eisei
Zasshi. 51 (2): 103-108; February, 2004.
43. Ipp, M.; Cohen, E.; Goldbach, M.; Macarthur, C. Effect of Choice of Measles-Mumps-
Rubella Vaccine on Immediate Vaccination Pain in Infants. Arch.Pediatr.Adolesc.Med. 158
(4): 323-326; April, 2004.
44. Jee, Y. M.; Cheon, D. S.; Kim, K. S.; Lee, S. H.; Yoon, J. D.; Lee, S. W.; Go, U.; Yang, B. K.;
Ki, M. R.; Choi, B. Y.; Cho, H. W. A Seroprevalence Study of Poliovirus Antibody Among
Primary Schoolchildren in Korea. Epidemiol.Infect. 132 (2): 351-355; April, 2004.
45. Kelly, H.; Worth, L.; Karapanagiotidis, T.; Riddell, M. Interruption of Rubella Virus
Transmission in Australia May Require Vaccination of Adult Males: Evidence From a
Victorian Sero-Survey. Commun.Dis.Intell. 28 (1): 69-73; 2004.
3/5

46. Krueger, M.; Fluegge, K.; Krause, M. F.; Berner, R. Fatal Haemophilus Influenzaetype b
Sepsis in a 10-Month-Old Infant Despite Complete Vaccination and Adequate Hib
Antibodies. Eur.J.Pediatr. April 15, 2004. [Epub ahead of print].
47. Kulkarni, V.; Nadgir, D.; Tapiawala, S.; Malabari, A.; Kalgikar, A.; Kela, R.; Nadkar, M.;
Kamath, S.; Shah, A. Biphasic Demyelination of the Nervous System Following Anti-Rabies
Vaccination. Neurol.India. 52 (1): 106-108; March, 2004.
48. Langue, J.; Matisse, N.; Pacoret, P.; Undreiner, F.; Boisnard, F.; Soubeyrand, B.
Persistence of Antibodies at 5-6 Years of Age for Children Who Had Received a Primary
Series Vaccination With a Pentavalent Whole-Cell Pertussis Vaccine and a First Booster
With a Pentavalent Acellular Pertussis Vaccine: Immunogenicity and Tolerance of Second
Booster With a Tetravalent Acellular Vaccine at 5-6 Years of Age. Vaccine. 22 (11-12):
1406-1414; March 29, 2004.
49. Letonturier, D. [Influenza Can Hide Other Infections]. Soins.Gerontol. (46): 42-45; March,
2004.
50. Mallet, E.; Matisse, N.; Mathieu, N.; Langue, J.; Boisnard, F.; Soubeyrand, B. Antibody
Persistence Against Diphtheria, Tetanus, Pertussis, Poliomyelitis and Haemophilus
Influenzae Type b (Hib) in 5-6-Year-Old Children After Primary Vaccination and First
Booster With a Pentavalent Combined Acellular Pertussis Vaccine: Immunogenicity and
Tolerance of a Tetravalent Combined Acellular Pertussis Vaccine Given As a Second
Booster. Vaccine. 22 (11-12): 1415-1422; March 29, 2004.
51. March, J. B. DNA Vaccination - Research Tool or a Practical Reality?
Expert.Rev.Vaccines. 3 (2): 113-117; April, 2004.
52. McLaughlin, M. A. Thoughts on Rabies Vaccination Enforcement. J.Am.Vet.Med.Assoc.
224 (6): 834-835; March 15, 2004.
53. Micco, E.; Gurmankin, A. D.; Armstrong, K. Differential Willingness to Undergo Smallpox
Vaccination Among African-American and White Individuals. J.Gen.Intern.Med. 19 (5 Pt 1):
451-455; May, 2004.
54. Morgan, O. W.; Meltzer, M.; Muir, D.; Hogan, H.; Seng, C.; Hill, J.; Beckford, J. Specialist
Vaccination Advice and Pockets of Resistance to MMR Vaccination: Lessons From an
Outbreak of Measles. Commun.Dis.Public Health. 6 (4): 330-333; December, 2003.
55. Mullooly, J. P.; Maher, J. E.; Drew, L.; Schuler, R.; Hu, W. Evaluation of the Impact of an
HMO's Varicella Vaccination Program on Incidence of Varicella. Vaccine. 22 (11-12): 1480-
1485; March 29, 2004.
56. Nolan, P. The Rhode Island Meningitis Vaccine Experience--Mass Vaccination
Campaigns, Politics and Health Policy. Med.Health R.I. 87 (3): 65-67; March, 2004.
57. Nookala, S.; Srinivasan, S.; Kaliraj, P.; Narayanan, R. B.; Nutman, T. B. Impairment of
Tetanus-Specific Cellular and Humoral Responses Following Tetanus Vaccination in
Human Lymphatic Filariasis. Infect.Immun. 72 (5): 2598-2604; May, 2004.
58. Parlato, A.; Marinelli, A.; Alfieri, R.; Albano, L.; Liguori, G. [The Tetanus in Italy and in the
Campania Region: Retrospective Analysis. The Importance of Vaccinations]. Ig Sanita
Pubbl. 59 (6): 383-392; November, 2003.
59. Parve, J. Remove Vaccination Barriers for Children 12 to 24 Months. Nurse Pract. 29
(4): 35-38; April, 2004.
4/5

60. Pazdiora, P.; Januska, J. [Dynamics of Antibody Formation After Vaccination Against
Tick-Borne Encephalitis]. Epidemiol.Mikrobiol.Imunol. 53 (1): 17-21; February, 2004.
61. Redd, S. C.; King, G. E.; Heath, J. L.; Forghani, B.; Bellini, W. J.; Markowitz, L. E.
Comparison of Vaccination With Measles-Mumps-Rubella Vaccine at 9, 12, and 15 Months
of Age. J.Infect.Dis. 189 Suppl 1:116-22; May 1, 2004.
62. Rosen, J. B.; Breman, J. G. Malaria Intermittent Preventive Treatment in Infants,
Chemoprophylaxis, and Childhood Vaccinations. Lancet. 363 (9418): 1386-1388; April 24,
2004.
63. Santibanez, T. A.; Zimmerman, R. K.; Nowalk, M. P.; Jewell, I. K.; Bardella, I. J. Physician
Attitudes and Beliefs Associated With Patient Pneumococcal Polysaccharide Vaccination
Status. Ann.Fam.Med. 2 (1): 41-48; January, 2004.
64. Singleton, J. A.; Wortley, P.; Lu, P. J. Influenza Vaccination of Persons With
Cardiovascular Disease in the United States. Tex.Heart Inst.J. 31 (1): 22-27; 2004.
65. Spoulou, V.; Giannaki, M.; Vounatsou, M.; Bakoula, C.; Grafakos, S. Long-Term Immunity
to Measles, Mumps and Rubella After MMR Vaccination Among Children With Bone
Marrow Transplants. Bone Marrow Transplant. April 12, 2004. [Epub ahead of print].
66. Staines, D. R. Is Osteoporosis Linked to Vaccinations and Gulf War Syndrome?
Med.Hypotheses. 62 (5): 670-673; 2004.
67. Uiterwyk, S. H. Pneumococcal Vaccine: to Vaccinate or to Revaccinate--That Is the
Question. Med.Health R.I. 87 (3): 68-71; March, 2004.
68. Valdmanis, V.; Walker, D.; Fox-Rushby, J. Are Vaccination Sites in Bangladesh Scale
Efficient? Int.J.Technol.Assess.Health Care. 19 (4): 692-697; 2003.
69. Wagenpfeil, S.; Neiss, A.; Banz, K.; Wutzler, P. Empirical Data on the Varicella Situation
in Germany for Vaccination Decisions. Clin.Microbiol.Infect. 10 (5): 425-430; May, 2004.
70. Wakefield, A. J.; Harvey, P.; Linnell, J. MMR--Responding to Retraction. Lancet. 363
(9417): 1327-1328; April 17, 2004.
71. Zhou, F.; Reef, S.; Massoudi, M.; Papania, M. J.; Yusuf, H. R.; Bardenheier, B.; Zimmerman,
L.; McCauley, M. M. An Economic Analysis of the Current Universal 2-Dose Measles-
Mumps-Rubella Vaccination Program in the United States. J.Infect.Dis. 189 Suppl 1:131-
45; May 1, 2004.
72. Zielinski, A.; Rosinska, M.; Czarkowski, M.; Rudowska, J. The Effectiveness of Vaccination
With Whole-Cell Pertussis Vaccine by Age Group in Poland 1996-2001. Scand.J.Infect.Dis.
36 (2): 114-118; 2004.
5/5